• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Mokecular Mechanism of Nuclear Receptor-mediated Chromatin Remodeling

Research Project

Project/Area Number 12672108
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionThe University of Tokyo

Principal Investigator

YANAGISAWA Junn  The University of Tokyo, Institute of Molecular and Cellular Sciences, Associate Professor, 分子細胞生物学研究所, 助教授 (50301114)

Co-Investigator(Kenkyū-buntansha) KATO Shigeaki  The University of Tokyo, Institute of Molecular and Cellular Sciences, Professor, 分子細胞生物学研究所, 教授 (60204468)
Project Period (FY) 2000 – 2001
KeywordsHormones / Chromatin / Estrogen / Nuclear Reseptors
Research Abstract

Nuclear receptors (NRs) ware thought to regulate transcription of their target genes in a ligand-dependent way through two types of co-activator complexes : The first includes histone acetyl transferases (HATs), such as CBP/p300, PCAF or the p160 family of proteins, while the second is large multiprotein complexes, called DRIP/TRAP/SMCC without HAT activity. Here we identified a large human (h) multiprotein co-activator complex necessary for activation of transcription by the estrogen receptor a (Erα). This complex contains the GCN5 HAT, the c-Myc interacting protein TRRAP/PAF400, the 30 kDa TATA binding protein (TBP) associated factor (TAF_<11>30), and other subunits, similarly to known TFTC (TBP-free TAF_<11>-containing)-type HAT complexes (hTFTC, hPCAF, hSTAGA and yeast SAGA). Direct and ligand-dependent interactions between Erα, or other NRs, and three LXXLL motifs of TRRAP were identified. In the cells Erα transaction was enhanced by co-expression of TRRAP with GCN5, and the purified GCN5 HAT complex potentiated the transaction function of liganded Erα in vitro. Moreover, expression of anti-sense TRRAP RNA inhibited oestrogen-dependent cell growth of breast cancer cells. Thus, the isolated TFTC-type HAT complex acts as a third class of co-activator complex for NR function.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Yanagisawa, J.: "Nuclear receptor requires a TFTC-type histone acetyl transferase complex"Molecular Cell. (印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitagawa, H.: "Ligand selective potentiation of rat mineralocorticoid receptor activation function (AF-1) by a CBP-containing HAT complex"Mol, Cell. Biol.. (印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mezaki, Y.: "N-terminal activation function isdominant in ligand-dependent transactivation of medaka estrogen receptor in human cells"B. B. R. C.. 289. 763-768 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamamoto, Y.: "A tamoxifen responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes"J. Biol. Chem.. 276(46). 42684(1)-42684(9) (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Watanabe, M.: "A subfamily of RNA binding DEAD-box proteins acts as an estrogen receptor coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA"EMBO J.. 20. 1341-1352 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yanagisawa J, Kitagawa H, Yanagida M, Wada 0, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, McMahon S. B, Cole M. D, Tora L, Takahashi N, Nagasawa H, Kato S.: "Nuclear receptor requires a TFTC-type histone acetyl transferase complex"Mol. Cell. in press. (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S.: "Ligand selective potentiation of rat mineralocorticoid receptor activation function (AF-1) by a CBP-containing HAT complex"Mol, Cell. Biol.. inpress. (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mezaki Y, Yoshida T, Yanagisawa J, Kato S.: "N-terminal activation function is dominant in ligand-dependent transactivation of medaka estrogen receptor _ in human cells"B. B. R. C.. 289. 763-8 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamamoto Y, Wada 0, Suzawa M, Yogiashi Y, Yano T, Kato S, Yanagisawa J: "A tamoxifen responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes"J. Biol. Chem.. 276(46). 42684-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Watanabe M, Yanagisawa J, Kitagawa H, Takeyama, K, Arao Y, Suzawa M, Kobayashi Y, Ogawa S, Yano T, Yoshikawa H, Masuhiro Y, Kato S.: "A subfamily of RNA binding DEAD-box proteins acts as an estrogen receptor _ coactivator through the N-terminal activation domain (AF-l) with an RNA coactivator, SRA"EMBO J.. 20. 1341-1352 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi